Skip to content

A randomized and controlled study of Qingjin Pingchuan recipe in treating severe pneumonia

A randomized and controlled study of Qingjin Pingchuan recipe in treating severe pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063694
Enrollment
Unknown
Registered
2022-09-14
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe pneumonia

Interventions

Qingjin Pingchuan Fang Group:Qingjin Pingchuan recipe
control group:Basic treatment
Qingjin Pingchuan Fang Group:Basic treatment

Sponsors

Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Age 18-80 years; ? Meet the criteria of severe community acquired pneumonia; ? The course of acute attack was within 3 days. ? Informed consent.

Exclusion criteria

Exclusion criteria: ? Allergic constitution or allergic to known ingredients of this medicine; ? Mental patients; ? Patients with lung abscess; ? Patients with malignant tumor; ? Combined with HIV positive patients; ? Those who do not meet the inclusion criteria, fail to take drugs according to the regulations, cannot determine the efficacy or incomplete data, etc., which affect the efficacy or safety judgment.

Design outcomes

Primary

MeasureTime frame
Case fatality rate on day 28;

Secondary

MeasureTime frame
Clinical improvement time within 28 days after randomization;Clinical improvement rates on days 7, 14, and 28 after randomization;

Countries

China

Contacts

Public ContactShirong
doctorshi@126.com13512143791

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026